08/13/2025
8:03 AM | Connect Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2025
8:04 AM | Connect Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/22/2025
8:07 AM | Connect Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2025
8:00 AM | Connect Biopharma (Subject)
Panacea Innovation Ltd (Filed by)
| Form SCHEDULE 13D/A | |
07/21/2025
8:05 AM | Connect Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2025
8:05 AM | Connect Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2025
8:05 AM | Connect Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2025
11:15 PM | Connect Biopharma (Filer)
| Form EFFECT | |
06/11/2025
7:02 AM | Connect Biopharma (Subject)
Wei Zheng (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2025
3:35 PM | Connect Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/14/2025
8:10 AM | Connect Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
8:10 AM | Connect Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
8:04 AM | Connect Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
8:02 AM | Connect Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
8:04 AM | Connect Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/23/2024
3:05 PM | Connect Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/06/2024
4:01 PM | Connect Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024
3:20 PM | Connect Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
MarketBeat All Access